Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InsuBiomm N versus Humulin N PK/PD clamp study in adults with type 1 diabetes
RBR-8b9npbPhase 1Not yet recruiting
- Sponsor
- ICF
- Start
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin isophane in diabetes mellitus type 1 (T1D) (2 arms), sponsored by ICF. Primary endpoints: Pharmacokinetics of NPH insulin and Pharmacodynamics of NPH insulin. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
insulin isophane
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on RBR-8b9npb.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8b9npb.